Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease (vol 27, pg 106, 2021)

被引：0
|
作者：
Daneses, Silvio [1 ,2 ,3 ]
机构：
[1] Humanitas Clin & Res Ctr IRCCS, Dept Gastroenterol, IBD Ctr, Rozzano, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Humanitas Clin & Res Ctr, Dept Gastroenterol, IBD Ctr, Milan, Italy
来源：
JOURNAL OF ANIMAL SCIENCE | 2022年 / 100卷 / 09期
关键词：
D O I：
暂无
中图分类号：
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号：
0905 ;
摘要：
引用
收藏
页码：1367 / 1367
页数：1
相关论文
共 50 条
  • [31] Infliximab for Crohn's disease in clinical practice at the mayo clinic: The first 100 patients
    Ricart, E
    Panaccione, R
    Loftus, EV
    Tremaine, WJ
    Sandborn, WJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (03): : 722 - 729
  • [32] Randomized Clinical Trial for Clinical Response Evaluation in Crohn's Disease: Infliximab Versus Adalimumab
    Baima, Julio
    Lima, Talles
    Moreira, Alecssandro
    de Barros, Jaqueline
    Dorna, Mariana
    da Silva, Rosemary
    Sibia, Carina
    Renosto, Fernanda
    Farinelli, Elen
    Saad-Hossne, Rogerio
    Sassaki, Ligia
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S30 - S30
  • [33] Efficacy and Safety of Adalimumab Biosimilar Dose Escalation Treatment in biologic naïve Patients With fistulas Crohn's Disease: A Prospective, Single-Arm Clinical Practice
    Cheng, Y.
    Wang, H.
    Yu, Q.
    Zhu, L.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1922 - i1922
  • [34] Early treatment with infliximab for Crohn's disease patients
    de Chambrun, G. Pineton
    Libier, L.
    Nachury, M.
    Collins, M.
    Koriche, D.
    Gower-Rousseau, C.
    Zerbib, P.
    Cortot, A.
    Colombel, J. -F.
    Desreumaux, P.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S251 - S252
  • [35] Early Treatment With Infliximab for Crohn's Disease Patients
    de Chambrun, Guillaume Pineton
    Libier, Louise
    Nachury, Maria
    Collins, Michael
    Koriche, Dine
    Gower-Rousseau, Corinne
    Zerbib, Philippe
    Cortot, Antoine
    Colombel, Jean-Frederic
    Desreumaux, Pierre
    GASTROENTEROLOGY, 2015, 148 (04) : S864 - S864
  • [36] Infliximab for the treatment of fistulas in patients with Crohn's disease
    Present, DH
    Rutgeerts, P
    Targan, S
    Hanauer, SB
    Mayer, L
    van Hogezand, RA
    Podolsky, DK
    Sands, BE
    Braakman, T
    DeWoody, KL
    Schaible, TF
    van Deventer, SJH
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18): : 1398 - 1405
  • [37] Crohn's disease - infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-α treatment
    Schreiber, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (34-35) : 1770 - 1774
  • [38] Efficacy and safety of infliximab versus adalimumab in the treatment of Crohn's disease: The McGill Experience
    Al-Taweel, T.
    Strohl, M.
    Kopylov, U.
    Paradis-Suprenant, L.
    Almaimany, M.
    Martel, M.
    Bitton, A.
    Afif, W.
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S369 - S369
  • [39] A single centre experience of adalimumab treatment in patients with luminal and fistulizing Crohn's disease: do antibodies to infliximab affect clinical outcome?
    West, R. L.
    Kuipers, E. J.
    van der Toorn, P.
    Buster, E. H. C. J.
    Mensink, P. B. F.
    Wolbink, G. J.
    van der Woude, C. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A3 - A4
  • [40] Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
    Barberio, Brigida
    Zingone, Fabiana
    D'Inca, Renata
    Rovigo, Laura
    Bertani, Lorenzo
    Bodini, Giorgia
    Ghisa, Matteo
    Gubbiotti, Alessandro
    Massimi, Davide
    Lorenzon, Greta
    Savarino, Edoardo Vincenzo
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11
12345